Joshua T Brumm - Net Worth and Insider Trading
Joshua T Brumm Net Worth
The estimated net worth of Joshua T Brumm is at least $14 Million dollars as of 2024-05-02. Joshua T Brumm is the CEO & President of Dyne Therapeutics Inc and owns about 537,998 shares of Dyne Therapeutics Inc (DYN) stock worth over $14 Million. Joshua T Brumm is also the COO and CFO of Aravive Inc and owns about 33,545 shares of Aravive Inc (ARAV) stock worth over $1,345. Details can be seen in Joshua T Brumm's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Joshua T Brumm has not made any transactions after 2024-03-11 and currently still holds the listed stock(s).
Transaction Summary of Joshua T Brumm
Joshua T Brumm Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Joshua T Brumm owns 4 companies in total, including Dyne Therapeutics Inc (DYN) , Kaleido Biosciences Inc (KLDO) , and Aravive Inc (ARAV) among others .
Click here to see the complete history of Joshua T Brumm’s form 4 insider trades.
Insider Ownership Summary of Joshua T Brumm
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2024-03-11 | director & See Remarks |
| KLDO | Kaleido Biosciences Inc | 2019-02-27 | See Remarks |
| ARAV | Aravive Inc | 2017-10-19 | Chief Financial Officer |
 | | 2012-02-17 | VP of Corporate Development |
Joshua T Brumm Latest Holdings Summary
Joshua T Brumm currently owns a total of 2 stocks. Among these stocks, Joshua T Brumm owns 537,998 shares of Dyne Therapeutics Inc (DYN) as of March 11, 2024, with a value of $14 Million and a weighting of 99.99%. Joshua T Brumm also owns 33,545 shares of Aravive Inc (ARAV) as of October 19, 2017, with a value of $1,345 and a weighting of 0.01%.
Latest Holdings of Joshua T Brumm
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| DYN | Dyne Therapeutics Inc | 2024-03-11 | 537,998 | 25.83 | 13,896,488 |
| ARAV | Aravive Inc | 2017-10-19 | 33,545 | 0.04 | 1,345 |
Holding Weightings of Joshua T Brumm
Joshua T Brumm Form 4 Trading Tracker
According to the SEC Form 4 filings, Joshua T Brumm has made a total of 12 transactions in Dyne Therapeutics Inc (DYN) over the past 5 years, including 0 buys and 12 sells. The most-recent trade in Dyne Therapeutics Inc is the sale of 429,730 shares on March 11, 2024, which brought Joshua T Brumm around $11 Million.
According to the SEC Form 4 filings, Joshua T Brumm has made a total of 0 transactions in Aravive Inc (ARAV) over the past 5 years. The most-recent trade in Aravive Inc is the sale of 221 shares on October 19, 2017, which brought Joshua T Brumm around $3,381.
Insider Trading History of Joshua T Brumm
- 1
Joshua T Brumm Trading Performance
GuruFocus tracks the stock performance after each of Joshua T Brumm's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Joshua T Brumm is -17.12%. GuruFocus also compares Joshua T Brumm's trading performance to market benchmark return within the same time period. The performance of stocks bought by Joshua T Brumm within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Joshua T Brumm's insider trading performs compared to the benchmark.
Performance of Joshua T Brumm
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 16.01 | | | | | |
| Relative Return to S&P 500(%) | 17.65 | | | | | |
Joshua T Brumm Ownership Network
Joshua T Brumm Owned Company Details
What does Dyne Therapeutics Inc do?
Who are the key executives at Dyne Therapeutics Inc?
Joshua T Brumm is the director & See Remarks of Dyne Therapeutics Inc. Other key executives at Dyne Therapeutics Inc include Chief Medical Officer Wildon Farwell , See Remarks Richard William Scalzo , and Chief Operating Officer Susanna Gatti High .
Dyne Therapeutics Inc (DYN) Insider Trades Summary
Over the past 18 months, Joshua T Brumm made 10 insider transaction in Dyne Therapeutics Inc (DYN) with a net sale of 1,171,794. Other recent insider transactions involving Dyne Therapeutics Inc (DYN) include a net sale of 241,325 shares made by Jonathan Mcneill , a net sale of 191,946 shares made by Richard William Scalzo , and a net sale of 32,676 shares made by Wildon Farwell .
In summary, during the past 3 months, insiders sold 4,521,380 shares of Dyne Therapeutics Inc (DYN) in total and bought 0 shares, with a net sale of 4,521,380 shares. During the past 18 months, 5,472,903 shares of Dyne Therapeutics Inc (DYN) were sold and 3,583,447 shares were bought by its insiders, resulting in a net sale of 1,889,456 shares.
Dyne Therapeutics Inc (DYN)'s detailed insider trading history can be found in Insider Trading Tracker table.
Dyne Therapeutics Inc Insider Transactions
Joshua T Brumm Mailing Address
Above is the net worth, insider trading, and ownership report for Joshua T Brumm. You might contact Joshua T Brumm via mailing address: Zeltiq Aesthetics Inc., 4698 Willow Road Suite 100, Pleasanton Ca 94588.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
